Acute uric acid nephropathy primary prevention

Jump to: navigation, search

Acute uric acid nephropathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute uric acid nephropathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

KUB X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute uric acid nephropathy primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute uric acid nephropathy primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute uric acid nephropathy primary prevention

CDC on Acute uric acid nephropathy primary prevention

Acute uric acid nephropathy primary prevention in the news

Blogs on Acute uric acid nephropathy primary prevention

Directions to Hospitals Treating Acute uric acid nephropathy

Risk calculators and risk factors for Acute uric acid nephropathy primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Primary Prevention

Patients at risk for acute uric acid nephropathy should be treated with allopurinol prior to treatment with cytotoxic drugs.

References


Linked-in.jpg